Thomas W Fredrick

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Replacement Therapy

Clostridium Difficile

Disease Activity

Top Venues

Crohn's & colitis 360

Journal of Crohn's & colitis

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas W Fredrick, Guilherme Piovezani Ramos, Manuel B Braga Neto, Sunanda V Kane, William A Faubion, Edward V Loftus, Darrell S Pardi, Shabana F Pasha, Francis A Farraye, Lizhi Zhang, Laura E Raffals
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis. Crohn's & colitis 360 4 (2) (2022)
Thomas W Fredrick, Guilherme Piovezani Ramos, Manuel B Braga Neto, Sunanda V Kane, William A Faubion, Edward V Loftus, Darrell S Pardi, Shabana F Pasha, Francis A Farraye, Lizhi Zhang, Laura E Raffals
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis. Crohn's & colitis 360 4 (2) (2022)
Rishika Chugh, Manuel B Braga Neto, Thomas W Fredrick, Guilherme P Ramos, Jonathan Terdiman, Najwa El-Nachef, Edward V Loftus, Uma Mahadevan, Sunanda V Kane
Multicenter Real-world Experience of Upadacitinib in the Treatment of Crohn's Disease. Journal of Crohn's & colitis (2022)
Thomas W Fredrick, Manuel B Braga Neto, Guilherme P Ramos, Sunanda V Kane, Darrell S Pardi, Laura E Raffals
Letter: safety of immune checkpoint inhibitors in patients with pre-established microscopic colitis-a single-centre experience. Alimentary pharmacology & therapeutics 54 (2) (2021)